These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 21262309)
1. A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40. Tsuruno C; Okuma K; Takahashi Y; Tanaka R; Tanaka Y; Takahama Y; Hamaguchi Y; Hamaguchi I; Yamaguchi K Hum Immunol; 2011 Apr; 72(4):295-304. PubMed ID: 21262309 [TBL] [Abstract][Full Text] [Related]
2. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577 [TBL] [Abstract][Full Text] [Related]
3. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine. Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639 [TBL] [Abstract][Full Text] [Related]
4. A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection. Okuma K; Fukagawa K; Kohma T; Takahama Y; Hamaguchi Y; Ito M; Tanaka Y; Buonocore L; Rose JK; Hamaguchi I Microbes Infect; 2017; 19(4-5):277-287. PubMed ID: 28025070 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein. Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111 [TBL] [Abstract][Full Text] [Related]
6. Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association. Zaitseva M; Romantseva T; Manischewitz J; Wang J; Goucher D; Golding H J Leukoc Biol; 2005 Dec; 78(6):1306-17. PubMed ID: 16204649 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992 [TBL] [Abstract][Full Text] [Related]
8. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282 [TBL] [Abstract][Full Text] [Related]
9. Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection. Okuma K; Boritz E; Walker J; Sarkar A; Alexander L; Rose JK Virology; 2006 Mar; 346(1):86-97. PubMed ID: 16325218 [TBL] [Abstract][Full Text] [Related]
10. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262 [TBL] [Abstract][Full Text] [Related]
11. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700 [TBL] [Abstract][Full Text] [Related]
12. Negative regulation of IL-17 production by OX40/OX40L interaction. Li J; Li L; Shang X; Benson J; Merle Elloso M; Schantz A; Bracht M; Orlovsky Y; Sweet R Cell Immunol; 2008; 253(1-2):31-7. PubMed ID: 18501882 [TBL] [Abstract][Full Text] [Related]
13. Characterization of rat OX40 ligand by monoclonal antibody. Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947 [TBL] [Abstract][Full Text] [Related]
14. Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26. Callebaut C; Jacotot E; Blanco J; Krust B; Hovanessian AG Exp Cell Res; 1998 Jun; 241(2):352-62. PubMed ID: 9637777 [TBL] [Abstract][Full Text] [Related]
15. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618 [TBL] [Abstract][Full Text] [Related]
16. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism. Blanco J; Barretina J; Clotet B; Esté JA J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189 [TBL] [Abstract][Full Text] [Related]
17. Decreased CD4 and wide-ranging expression of other immune receptors after HIV-envelope-mediated formation of syncytia in vitro. Rivera-Toledo E; López-Balderas N; Huerta L; Lamoyi E; Larralde C Arch Virol; 2010 Aug; 155(8):1205-16. PubMed ID: 20508956 [TBL] [Abstract][Full Text] [Related]
18. Serial OX40 engagement on CD4+ T cells and natural killer T cells causes allergic airway inflammation. Damayanti T; Kikuchi T; Zaini J; Daito H; Kanehira M; Kohu K; Ishii N; Satake M; Sugamura K; Nukiwa T Am J Respir Crit Care Med; 2010 Apr; 181(7):688-98. PubMed ID: 20019337 [TBL] [Abstract][Full Text] [Related]
19. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model. Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881 [TBL] [Abstract][Full Text] [Related]
20. Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation. Rutjens E; Vermeulen J; Verstrepen B; Hofman S; Prins JM; Srivastava I; Heeney JL; Koopman G Eur J Immunol; 2008 Apr; 38(4):1164-72. PubMed ID: 18383039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]